Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12558 | 897 | 37.1 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
827 | 2 | MAMMOGRAPHIC DENSITY//BREAST DENSITY//METFORMIN | 11860 |
12558 | 1 | UNIV INTEGRATED HOSP//PROSTATE CANCER//TOTAL TESTOSTERONE TT | 897 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | UNIV INTEGRATED HOSP | address | 204241 | 1% | 100% | 6 |
2 | PROSTATE CANCER | authKW | 159948 | 39% | 1% | 354 |
3 | TOTAL TESTOSTERONE TT | authKW | 136161 | 0% | 100% | 4 |
4 | FREE TESTOSTERONE FT | authKW | 121569 | 1% | 71% | 5 |
5 | PERIPROSTATIC ADIPOSE TISSUE | authKW | 121569 | 1% | 71% | 5 |
6 | PERIPROSTATIC FAT | authKW | 102121 | 0% | 100% | 3 |
7 | DUKE PROSTATE | address | 97102 | 3% | 11% | 25 |
8 | DUKE PROSTATE CANC | address | 76589 | 0% | 75% | 3 |
9 | PROSTATE SPECIFIC ANTIGEN | authKW | 74745 | 10% | 2% | 89 |
10 | PROSTATIC NEOPLASMS | authKW | 71390 | 11% | 2% | 102 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 21930 | 45% | 0% | 408 |
2 | Oncology | 5597 | 41% | 0% | 370 |
3 | Public, Environmental & Occupational Health | 970 | 14% | 0% | 130 |
4 | Endocrinology & Metabolism | 764 | 12% | 0% | 110 |
5 | Andrology | 314 | 1% | 0% | 11 |
6 | Nutrition & Dietetics | 13 | 2% | 0% | 15 |
7 | Medicine, General & Internal | 8 | 3% | 0% | 29 |
8 | Medicine, Research & Experimental | 7 | 2% | 0% | 21 |
9 | Radiology, Nuclear Medicine & Medical Imaging | 2 | 2% | 0% | 18 |
10 | Pathology | 0 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIV INTEGRATED HOSP | 204241 | 1% | 100% | 6 |
2 | DUKE PROSTATE | 97102 | 3% | 11% | 25 |
3 | DUKE PROSTATE CANC | 76589 | 0% | 75% | 3 |
4 | INTERNAL MED ENDOCRINOL SECT | 61270 | 0% | 60% | 3 |
5 | UROL | 51800 | 45% | 0% | 408 |
6 | BCGI | 34040 | 0% | 100% | 1 |
7 | BIOL SPECIALISEE ONCONGENET | 34040 | 0% | 100% | 1 |
8 | BOARD HLTH WELF CANC EPIDEMIOL | 34040 | 0% | 100% | 1 |
9 | CELLULAR STRUCT BIOL UROL | 34040 | 0% | 100% | 1 |
10 | CHEM CLIN DIAGNOST | 34040 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTATE CANCER AND PROSTATIC DISEASES | 30314 | 3% | 3% | 31 |
2 | PROSTATE | 21017 | 6% | 1% | 53 |
3 | CANCER CAUSES & CONTROL | 16684 | 4% | 1% | 40 |
4 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 13487 | 6% | 1% | 50 |
5 | BJU INTERNATIONAL | 9610 | 5% | 1% | 48 |
6 | UROLOGY | 6747 | 6% | 0% | 57 |
7 | ACTAS UROLOGICAS ESPANOLAS | 3454 | 1% | 1% | 10 |
8 | CLINICAL ONCOLOGY-US | 3402 | 0% | 10% | 1 |
9 | JOURNAL OF UROLOGY | 3252 | 6% | 0% | 52 |
10 | UROLOGIA INTERNATIONALIS | 2664 | 2% | 0% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROSTATE CANCER | 159948 | 39% | 1% | 354 | Search PROSTATE+CANCER | Search PROSTATE+CANCER |
2 | TOTAL TESTOSTERONE TT | 136161 | 0% | 100% | 4 | Search TOTAL+TESTOSTERONE+TT | Search TOTAL+TESTOSTERONE+TT |
3 | FREE TESTOSTERONE FT | 121569 | 1% | 71% | 5 | Search FREE+TESTOSTERONE+FT | Search FREE+TESTOSTERONE+FT |
4 | PERIPROSTATIC ADIPOSE TISSUE | 121569 | 1% | 71% | 5 | Search PERIPROSTATIC+ADIPOSE+TISSUE | Search PERIPROSTATIC+ADIPOSE+TISSUE |
5 | PERIPROSTATIC FAT | 102121 | 0% | 100% | 3 | Search PERIPROSTATIC+FAT | Search PERIPROSTATIC+FAT |
6 | PROSTATE SPECIFIC ANTIGEN | 74745 | 10% | 2% | 89 | Search PROSTATE+SPECIFIC+ANTIGEN | Search PROSTATE+SPECIFIC+ANTIGEN |
7 | PROSTATIC NEOPLASMS | 71390 | 11% | 2% | 102 | Search PROSTATIC+NEOPLASMS | Search PROSTATIC+NEOPLASMS |
8 | RM1 CELLS | 68080 | 0% | 100% | 2 | Search RM1+CELLS | Search RM1+CELLS |
9 | PSA MASS | 45386 | 0% | 67% | 2 | Search PSA+MASS | Search PSA+MASS |
10 | BODY MASS INDEX | 37005 | 12% | 1% | 111 | Search BODY+MASS+INDEX | Search BODY+MASS+INDEX |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CAO, Y , MA, J , (2011) BODY MASS INDEX, PROSTATE CANCER-SPECIFIC MORTALITY, AND BIOCHEMICAL RECURRENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS.CANCER PREVENTION RESEARCH. VOL. 4. ISSUE 4. P. 486 -501 | 46 | 75% | 126 |
2 | FREEDLAND, SJ , PLATZ, EA , (2007) OBESITY AND PROSTATE CANCER: MAKING SENSE OUT OF APPARENTLY CONFLICTING DATA.EPIDEMIOLOGIC REVIEWS. VOL. 29. ISSUE . P. 88-97 | 68 | 59% | 102 |
3 | BUSCHEMEYER, WC , FREEDLAND, SJ , (2007) OBESITY AND PROSTATE CANCER: EPIDEMIOLOGY AND CLINICAL IMPLICATIONS.EUROPEAN UROLOGY. VOL. 52. ISSUE 2. P. 331-343 | 66 | 55% | 123 |
4 | KLAP, J , SCHMID, M , LOUGHLIN, KR , (2015) THE RELATIONSHIP BETWEEN TOTAL TESTOSTERONE LEVELS AND PROSTATE CANCER: A REVIEW OF THE CONTINUING CONTROVERSY.JOURNAL OF UROLOGY. VOL. 193. ISSUE 2. P. 403 -413 | 36 | 80% | 11 |
5 | HSING, AW , SAKODA, LC , CHUA, SC , (2007) OBESITY, METABOLIC SYNDROME, AND PROSTATE CANCER.AMERICAN JOURNAL OF CLINICAL NUTRITION. VOL. 86. ISSUE 3. P. 843S-857S | 46 | 61% | 143 |
6 | ALLOTT, EH , MASKO, EM , FREEDLAND, SJ , (2013) OBESITY AND PROSTATE CANCER: WEIGHING THE EVIDENCE.EUROPEAN UROLOGY. VOL. 63. ISSUE 5. P. 800-809 | 42 | 46% | 117 |
7 | PIERCE, BL , (2012) WHY ARE DIABETICS AT REDUCED RISK FOR PROSTATE CANCER? A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE.UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. VOL. 30. ISSUE 5. P. 735 -743 | 47 | 59% | 16 |
8 | HU, MB , XU, H , BAI, PD , JIANG, HW , DING, Q , (2014) OBESITY HAS MULTIFACETED IMPACT ON BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: A DOSE-RESPONSE META-ANALYSIS OF 36,927 PATIENTS.MEDICAL ONCOLOGY. VOL. 31. ISSUE 2. P. - | 31 | 79% | 8 |
9 | DIMITROPOULOU, P , MARTIN, RM , TURNER, EL , LANE, JA , GILBERT, R , DAVIS, M , DONOVAN, JL , HAMDY, FC , NEAL, DE , (2011) ASSOCIATION OF OBESITY WITH PROSTATE CANCER: A CASE-CONTROL STUDY WITHIN THE POPULATION-BASED PSA TESTING PHASE OF THE PROTECT STUDY.BRITISH JOURNAL OF CANCER. VOL. 104. ISSUE 5. P. 875 -881 | 40 | 68% | 9 |
10 | TOMASZEWSKI, JJ , CHEN, YF , BERTOLET, M , RISTAU, BT , WOLDEMICHAEL, E , NELSON, JB , (2013) OBESITY IS NOT ASSOCIATED WITH AGGRESSIVE PATHOLOGIC FEATURES OR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY.UROLOGY. VOL. 81. ISSUE 5. P. 992-996 | 26 | 90% | 8 |
Classes with closest relation at Level 1 |